First HSV-1 genital episodes in HSV-2 infected patients however, had never been demonstrated until the 2 cases we observed. This scarcity could reflect the lower impact of HSV-2 on western populations but questions the existence of cross-protection between viral types.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2016.03.018DOI Listing

Publication Analysis

Top Keywords

hsv-1 primary
4
primary genital
4
genital herpes
4
herpes patients
4
patients hsv-1
4
hsv-1 genital
4
genital episodes
4
episodes hsv-2
4
hsv-2 infected
4
infected patients
4

Similar Publications

Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice.

View Article and Find Full Text PDF

Background And Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir.

Materials And Methods: In our experimental study, was dissolved in DMSO, then diluted in DMEM medium.

View Article and Find Full Text PDF

Herpes simplex keratitis (HSK), an ocular disease resulted from herpes simplex virus type 1 (HSV-1) infection, leads to the majority of infectious corneal blindness worldwide. The apoptosis of corneal epithelial cells (CECs) resulted from HSV-1 disrupts the epithelial barrier and exacerbates the infection; however, there is no definitive cure for HSK. Jagged1 (JAG1), one of the primary functional ligands for NOTCH receptors, plays a crucial role in regulating apoptosis and autophagy; however, its role in HSK is unclear.

View Article and Find Full Text PDF

Herpes simplex virus-1 (HSV-1) is the primary cause of infectious blindness. Despite impressive therapeutic outcomes of conventional treatments, HSV-1 drug resistance can be easily developed. Thus, more constructive strategies should be implemented.

View Article and Find Full Text PDF
Article Synopsis
  • Gene therapy is being explored for xeroderma pigmentosum (XP), a genetic condition that greatly increases the risk of skin cancer due to defective DNA repair.
  • Large gene sizes pose challenges for traditional gene therapy methods, but researchers have developed artificial chromosome vectors to successfully deliver and express larger genes.
  • A dual transduction system was created, allowing the introduction of genes over 100 Kb into human cells, and it was demonstrated that this method works for both human fibrosarcoma cells and patient cells lacking the XPC gene.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!